Front-line chemoimmunotherapy for treating epithelial ovarian cancer: Part II promising results of phase 2 study of paclitaxel-carboplatin-oregovomab regimen.

paclitaxel - Generic mfg.

carboplatin - Generic mfg.

OvaRex (oregovomab) - CanariaBio

http://www.ncbi.nlm.nih.gov/pubmed/38216242

Fang-Wei Chou; Hung-Hsien Liu; Peng-Hui Wang; Szu-Ting Yang; Wen-Hsun Chang; Wen-Ling Lee

Jan 13, 2024